title: [Spontaneous reperfusion of the infarct-related artery in patients with ST elevated myocardial infarction].
abstract: OBJECTIVE
  To characterize a clinical course of ST elevation myocardial infarction (STEMI) and spontaneous reperfusion of the coronary arteries (SR) as well as in patients after reperfusion thrombolytic therapy (TLT) and/or transluminal balloon coronary angioplasty (TBCA); to compare effectiveness of different approaches to treatment of SR patients: conservative--early medication and active--TBCA on the first postmyocardial 24 hours.
  
  
  METHODS
  We studied 479 patients admitted to hospital not later than 6 hours since STEMI onset and either having SR (n = 49) or treated using active methods of coronary circulation restoration--prehospital thrombolysis (n = 127), thrombolysis after hospitalization (n = 127), primary TBCA (n = 60) and TBCA after initiation of TLT (n = 116). We made a more detailed analysis on the sample of 149 SR patients.
  
  
  RESULTS
  SR was diagnosed in 10.2% cases with STEMI and occurred much earlier than recovery of coronary circulation due to TLT and/or TBCA. Patients with SR developed Q-MI, right ventricular infarction, cardiac failure and atrioventricular block less frequently. They had the lowest peak activity of creatin phosphokinase and a higher left ventricular ejection fraction versus patients without SR (50.7 +/- 6.8 and 45.4 +/- 6.6%, respectively; p < 0.05). As shown by coronaroangiography, SR patients had no "no reflow" phenomenon (0% and 17%, respectively). Active policy of SR patients treatment had no significant advantages over conservative treatment.
  
  
  CONCLUSIONS
  Early SR had more favourable course of MI, less mass of the affected myocardium and better contractile function of the left ventricle. The conservative policy of STEMI treatment in the presence of SR is more effective than the active one if a due control over the patients' condition is provided.
authors.forename: M Ia
authors.initials: MIa
authors.lastname: Ruda
authors.forename: A I
authors.initials: AI
authors.lastname: Kuz'min
authors.forename: I N
authors.initials: IN
authors.lastname: Merkulova
authors.forename: A N
authors.initials: AN
authors.lastname: Samko
authors.forename: E V
authors.initials: EV
authors.lastname: Merkulov
authors.forename: A V
authors.initials: AV
authors.lastname: Sozykin
authors.forename: D U
authors.initials: DU
authors.lastname: Akasheva
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D003326:Coronary Circulation / Q000502:physiology; D003331:Coronary Vessels / Q000000981:diagnostic imaging*; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D012008:Recurrence; D012075:Remission, Spontaneous; D013997:Time Factors; D014463:Ultrasonography
chemical_list: D005343:Fibrinolytic Agents